Task: Answer the multiple choice question.
Question: Which drug exhibits a -81.526% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a.) COc1ccc(CCC(=O)N2CCN(c3ccc([N+](=O)[O-])cc3)CC2)cc1OC
b.) C=CCN1C(=O)C(Cc2ccc(SC(F)F)cc2)SC1=Nc1ccc(C(=O)O)cc1
c.) COc1ccc(C(=O)n2cnc(N)n2)cc1
d.) COc1cc(Br)cc2cc(C(=O)N3CCOCC3)c(=O)oc12
e.) COCCSc1nnc(NS(=O)(=O)Cc2ccccc2)s1
Answer: a. COc1ccc(CCC(=O)N2CCN(c3ccc([N+](=O)[O-])cc3)CC2)cc1OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(CCC(=O)N2CCN(c3ccc([N+](=O)[O-])cc3)CC2)cc1OC
COc1ccc(CCC(=O)N2CCN(c3ccc([N+](=O)[O-])cc3)CC2)cc1OC
3-(3,4-dimethoxyphenyl)-1-[4-(4-nitrophenyl)piperazin-1-yl]propan-1-one